Detection of rpoB mutations missed by routine diagnostic assays using targeted sequencing in NGS

Rifampicin resistance conferring mutations outside the rifampicin resistance determining region (RRDR), those were missed by routine phenotypic and genotypic drug susceptibility tests, were recently detected in treatment failure cases in Myanmar.